Mesa Laboratories Quarterly Cash Flow Statement
NASDAQ: MLABIndustrialsIndustrial Machinery/ComponentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Mesa Laboratories free cash flow
In the quarter ended Jun 30, 2026, Mesa Laboratories generated $14.7 million of operating cash flow and spent $559,000 on capital expenditures. That left free cash flow of $14.2 million, a free-cash-flow margin of 23.6% of revenue. Free cash flow was up 1503.7% from the prior year's $884,000.
Mesa Laboratories returned $884,000 to shareholders through dividends, equal to 6% of free cash flow. Free cash flow covered dividend payments 16.0 times.
Summary generated from market data by MetaCap's automated system. Methodology
Mesa Laboratories cash flow statement (quarterly)
| Quarter (USD) | Q1 20272026-06-30 | Q4 20262026-03-31 | Q3 20252025-12-31 | Q2 20252025-09-30 | Q1 20252025-06-30 | Q4 20252025-03-31 | Q3 20252024-12-31 | Q2 20252024-09-30 | Q1 20252024-06-30 | Q4 20242024-03-31 | Q3 20242023-12-31 | Q2 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 2.83M | -4.14M | 3.63M | 2.48M | 4.74M | -7.11M | -1.68M | 3.43M | 3.39M | -254.58M | 2.12M | -1.23M |
| Net Income growth (YoY) | -40.32% | — | — | -27.77% | +39.96% | — | -179.21% | — | — | -41766.61% | +369.18% | -194.18% |
| Depreciation & Amortization | 1.25M | 1.26M | 1.27M | 1.31M | 1.40M | 1.35M | 1.11M | 1.52M | 1.40M | 1.33M | 1.07M | 8.10M |
| Stock-Based Compensation | 2.36M | 6.79M | 3.38M | 3.81M | 3.88M | 3.14M | 3.24M | 3.84M | 2.93M | 2.79M | 2.99M | 3.18M |
| Change in Working Capital | 5.20M | 1.78M | 5.20M | -7.06M | -5.51M | 9.67M | 2.71M | -6.09M | 113.00K | 509.00K | 4.21M | -278.00K |
| Operating Cash Flow | 14.74M | 13.96M | 18.75M | 8.22M | 1.89M | 12.66M | 18.13M | 5.27M | 10.74M | 12.88M | 11.54M | 9.78M |
| Capital Expenditures | -559.00K | -417.00K | -732.00K | -1.09M | -1.01M | -757.00K | -813.00K | -1.79M | -891.00K | -535.00K | -1.13M | -634.00K |
| Investing Cash Flow | -559.00K | -417.00K | -732.00K | -1.09M | -1.01M | -1.01M | -813.00K | -1.79M | -891.00K | 426.00K | -80.83M | -634.00K |
| Dividends Paid | -884.00K | -884.00K | -884.00K | -882.00K | -873.00K | -870.00K | -869.00K | -866.00K | -863.00K | -864.00K | -862.00K | -862.00K |
| Debt Repaid | -18.66M | -14.69M | -8.69M | -5.94M | -7.44M | -17.94M | -9.44M | -7.44M | -9.44M | -11.50M | -9.00M | -5.00M |
| Financing Cash Flow | -10.50M | -15.76M | -9.79M | -7.88M | -8.43M | -16.19M | -10.29M | -8.61M | -9.42M | -12.93M | 60.85M | -5.56M |
| Net Change in Cash | 3.77M | -2.05M | 8.55M | -857.00K | -6.04M | -3.63M | 6.62M | -4.13M | 258.00K | -10.00K | -7.39M | 3.24M |
| Free Cash Flow | 14.18M | 13.54M | 18.02M | 7.13M | 884.00K | 11.91M | 17.32M | 3.48M | 9.85M | 12.35M | 10.41M | 9.14M |
This table shows 12 quarterly periods of Mesa Laboratories's cash flow statement, from Q1 2027 back to Q2 2024, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MLAB's reporting calendar. What is a cash flow statement?